Fortitude Re's $3.8B Deal Moves 26% of Unum's LTC Risk Off Balance

Unum ceded $3.8 billion of individual long-term care statutory reserves to Fortitude Re on July 6, 2026, its second cession to the reinsurer in 17 months, covering roughly 50,000 policies and 26% of Unum's total LTC reserves while leaving its $11 billion group LTC block untouched (Unum, July 2026).

A Second Cession in 17 Months

Unum Group and Fortitude Reinsurance Company Ltd. announced the transaction on July 6, 2026. Unum will recapture an individual LTC block from its subsidiary Fairwind Insurance Company and cede it to Fortitude Re, transferring $3.8 billion of statutory reserves and approximately $4.5 billion of best-estimate reserves tied to roughly 50,000 individual policies (BusinessWire/Unum, July 6, 2026). The block represents 26% of Unum's total LTC reserves and 52% of its individual LTC reserves as of March 31, 2026, a scale that pushes Unum's remaining LTC statutory reserves down to approximately $11.0 billion, about 70% of which now backs group LTC business (Unum, July 2026). Unum keeps every part of the customer relationship. Claims handling, premium rate-increase program administration, and day-to-day servicing all stay in-house, while the economic risk moves to Fortitude Re's balance sheet.

"This marks another important step in advancing our Closed Block strategy to further reduce exposure to legacy long-term care business," said Richard P. McKenney, Unum's president and CEO (Unum, July 2026). Kai Talarek, Fortitude Re's chief growth and optimisation officer, framed the deal as a repeat engagement rather than a one-off transaction: "We are pleased to again partner with Unum and value the trust they have placed in our team" (Reinsurance News, July 2026). The transaction is expected to close during 2026 subject to regulatory approval, funded through a combination of Fairwind's excess capital, holding-company liquidity, and financing tied to future tax benefits. Once it settles, Unum projects year-end 2026 holding-company liquidity of $1.5 billion to $2.0 billion, leverage near 25%, and an RBC ratio of 400% to 425% (Unum, July 2026).

Why the Group Book Stayed and the Individual Book Went

The transaction is a selection decision as much as it is a capital-relief transaction, and the selection logic tracks a mispricing pattern this site has documented in detail across the broader LTC market. Individual policies written through the 1980s and 1990s were priced on lapse assumptions of roughly 4% to 5% annually that turned out to run closer to 1%, and on morbidity tables that underestimated both claim incidence and claim duration, as our coverage of the SOA/Milliman rate-increase survey has laid out: carriers requested a 56% average increase nationwide and states approved just 28% of it. Individual LTC policies are guaranteed renewable, carry decades of underwriting vintage baked into their original pricing, and every subsequent rate increase has to clear a state-by-state approval process that averages six months and delivers roughly a quarter of what carriers ask for. Group LTC is a different animal. It is typically employer-sponsored and repriced on a renewal cycle closer to group health insurance, carries less anti-selection because enrollment happens through a workplace population rather than a fully underwritten individual purchase decision, and turns over faster as plan sponsors switch carriers or discontinue the benefit.

The disclosed percentages let you back into how sharply this transaction shifts Unum's mix. If $3.8 billion of individual reserves equals 52% of Unum's individual LTC book, the individual block stood at roughly $7.3 billion immediately before the deal; if that same $3.8 billion equals 26% of the combined individual-plus-group total, the pre-deal combined book was close to $14.6 billion, implying a roughly even split between individual and group reserves heading into the transaction. After the cession, the arithmetic flips: individual reserves fall to about $3.5 billion against a group book holding steady near $7.3 billion, moving the mix from an even split to something closer to 30% individual and 70% group, consistent with the "approximately 70%" group share Unum disclosed for the post-transaction book. Unum did not simply shrink its LTC exposure by a quarter. It deliberately rebalanced away from the half of the portfolio that has been harder to price for thirty years.

Two Steps Removed From the Policyholder

Fortitude Re is not retaining the insurance risk it is assuming. The company will retrocede 100% of the LTC risk to what both companies describe only as a "highly rated global reinsurance partner," an arrangement that mirrors the February 2025 transaction, in which Fortitude Re likewise retroceded biometric risk to an unnamed "highly rated global reinsurer" (Unum investor relations, 2025; Reinsurance News, July 2026). Fortitude Re's own disclosed role is limited to the spread-based, asset-management side of the transaction, backed by its relationship with Carlyle Group as strategic investment partner (Royal Gazette, July 2026).

For the original Unum policyholder, the risk-bearing chain now runs three layers deep: a primary insurer that still handles claims but no longer holds the economic risk, a Bermuda reinsurer that structures the deal and manages the assets, and an undisclosed retrocessionaire that actually stands behind the eventual claim payments. That structure carries two consequences worth naming directly. An appointed actuary's asset adequacy testing on the ceding side has to get comfortable with the collectability of reinsurance recoverables from a counterparty whose identity is not public, a materially different exercise than assessing a named, rated reinsurer's claims-paying ability. And state regulators trying to monitor concentration risk across the LTC reinsurance market are working from an incomplete picture: if Fortitude Re and other active LTC reinsurers are retroceding to a smaller set of ultimate capacity providers than the number of publicly announced transactions suggests, the market's real counterparty concentration could run higher than the deal count implies.

Roughly 40% of LTC Reserves Gone in 17 Months

Unum's two transactions with Fortitude Re, taken together, cede more than $7 billion of LTC statutory reserves in 17 months. The first closed on July 1, 2025, transferring $3.4 billion, representing 19% of Unum's total LTC block and generating approximately $100 million of capital benefit (Unum investor relations, 2025). The second, announced this week, adds $3.8 billion more. Working back from the disclosed percentages, Unum's total LTC statutory reserves stood near $17.9 billion before the first transaction ($3.4 billion divided by 19%) and sit near $11.0 billion today, a reduction of roughly 38% to 40% of the original book in under a year and a half.

Unum is not alone in moving at this pace. Manulife ceded C$6.0 billion of in-force LTC business to Global Atlantic at the end of 2023 and followed with a $2.4 billion, 75% quota-share cession to RGA in November 2024 that alone represented 6% of Manulife's total LTC reserves as of September 30, 2024; combined, Manulife reports the two transactions cumulatively reduced its LTC reserves by 18% and its LTC morbidity sensitivity by 17% (Manulife/RGA, November 2024). Not every legacy carrier is taking the reinsurance route, however. Genworth, which still carries one of the largest individual LTC blocks in the country, has instead leaned entirely on in-force rate actions, reporting an estimated $31.2 billion of cumulative economic benefit on a net present value basis from approved premium increases and benefit reductions from 2012 through 2024 (Genworth, Q4 2025 earnings release). Unum and Manulife are transferring legacy LTC risk off their balance sheets; Genworth is grinding through the state-by-state rate-approval process that, as this site has reported, delivers roughly 28 cents of approval for every dollar requested. Both are defensible actuarial responses to the same underlying problem, and the split between them is itself a data point on how differently carriers are pricing the cost of capital tied up in legacy LTC reserves against the execution risk of a reinsurance transaction.

The $700 Million Reserve Gap

The transaction also discloses a smaller but analytically interesting number: Fortitude Re is assuming $4.5 billion of best-estimate reserves against the $3.8 billion of statutory reserves being ceded, a $700 million gap between the two bases (Unum, July 2026). Statutory reserves for individual LTC business are typically calculated using a net level premium method built on the lapse, morbidity, and interest assumptions locked in at original policy issue, assumptions this site has covered as running too optimistic across the industry, with actual lapse near 1% against original pricing assumptions of 4% to 5%. A best-estimate figure that runs $700 million above the corresponding statutory reserve is consistent with that same pattern: the formula-driven statutory basis, still anchored to decades-old pricing assumptions, understates the block's current expected ultimate cost relative to an actuary's best estimate of what the business will actually pay out. For a reserving actuary evaluating a comparable block elsewhere, that $700 million gap is a useful benchmark for how far a legacy LTC statutory reserve can run below a defensible best-estimate view before a carrier decides reinsurance, rather than another rate filing, is the more efficient way to close it.

Why This Matters for Actuaries

For reserving actuaries at other carriers still holding meaningful individual LTC exposure, principally Genworth, CNO Financial, and John Hancock's closed block, the Unum transaction sets a fresh market data point for how a statutory-to-best-estimate gap of this size gets cleared through a live reinsurance transaction rather than carried indefinitely on the balance sheet. For capital and ALM actuaries, the pattern across Unum and Manulife suggests legacy LTC reserves are being treated less like a permanent balance sheet feature and more like a disposable liability whenever a counterparty is willing to underwrite the retrocession risk, which raises the practical question of how much retrocession capacity actually exists behind the small number of named reinsurers active in this market. For actuaries advising state regulators, the undisclosed retrocessionaire in both the 2025 and 2026 Fortitude Re transactions is worth flagging directly: aggregate counterparty concentration across the LTC reinsurance market cannot be fully assessed from public disclosures alone.

Whether a roughly 40% reduction in one carrier's LTC statutory reserves over 17 months becomes the market's new pace or stays an outlier will depend on how much retrocession capacity the handful of active buyers can absorb. Carriers still sitting on large, harder-to-price individual LTC blocks now have two recent, well-documented transactions to benchmark against, and neither one required the cedent to give up the underlying customer relationship to get the risk off its books.